Rankings
▼
Calendar
ORGO Q2 2018 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena
ORGO
Organogenesis Holdings Inc.
$338M
Q2 2018 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$0
Gross Profit
-$942,527
Operating Income
-$942,527
Net Income
$356,988
EPS (Diluted)
$-0.30
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$210,082
Free Cash Flow
-$210,082
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$315M
Total Liabilities
$17M
Stockholders' Equity
$298M
Cash & Equivalents
$64,411
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$942,527
-$221,808
-324.9%
Operating Income
-$942,527
-$221,808
-324.9%
Net Income
$356,988
$380,334
-6.1%
← FY 2018
All Quarters
Q3 2018 →